Cellular Therapies: Should we be concerned about ZIKA virus?

Should there be cause for additional concerns or worries in the cellular therapy laboratory (CTL) from the recent emergence of the Zika virus and its categorization as a relevant communicable disease agent or disease as defined in 21 CFR Part 1271? The FDA recently published the new guidance for HCT/Ps... read more